Core Viewpoint - Company expects a net loss of 450 million to 640 million yuan for the year 2025, with a projected net profit excluding non-recurring losses ranging from -770 million to -540 million yuan [1] Group 1: Financial Performance - The company's bioenergy segment revenue increased by approximately 580 million yuan, representing a year-on-year growth of about 46% due to rising product prices and capacity release [1] - The gross profit for the bioenergy segment increased by approximately 270 million yuan, leading to a turnaround from loss to profit, significantly enhancing operational efficiency [1] - The company anticipates asset impairment losses of around 250 million yuan for the reporting period, based on cautious principles and evaluations of inventory and fixed assets [1] Group 2: Market Environment - The global green energy policy environment continues to improve, with the EU and UK implementing regular biojet fuel (SAF) blending policies, and major economies like China, Japan, and South Korea clarifying their green transition paths [1] - The company successfully obtained approval for SAF product export in October 2025, marking a strategic breakthrough in its development [1] Group 3: Challenges in Other Segments - The company's environmental materials and chemical products business faced challenges due to cyclical adjustments in the petroleum refining and coal chemical industries, leading to a pressured market environment for catalyst and purification products [1] - The rapid expansion of capacity in the LNG and neopentyl glycol industries outpaced demand growth, exacerbating competition within the industry [1]

海新能科公告，预计2025年度归属于上市公司股东的净利润为-6.4亿元至-4.5亿元，同比减亏。报告期 内，公司环保材料及化工产品业务面临挑战。受石油炼化及煤化工产业周期性调整影响，国内催化剂净 化剂业务市场环境承压；同时，煤气清洁利用（LNG）及新戊二醇行业阶段性产能扩张快于需求增 长，供需失衡加剧行业竞争。在上述因素综合影响下，该业务板块营业收入及净利润同比出现下滑。 ...